i2020 Accelerator Invests in Developing Novel Highly-Specific Approaches to Treatment of Neurodegenerative Diseases Based on Previously Unrecognized Protein-Protein Interactions
i2020 Accelerator announced today its plans to invest in a cutting-edge research program based out of the University of Turku (UTU), Finland.